Skip to Main Content

Paper Details

Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD).
Transl Oncol
3
2023
BRCA1, BRCA1/2, BRCA1/2-mutated tumors, HRD, HRDsum, HRR, HRR genes, Homologous recombination deficiency, PARPi, Tumor, homologous recombination deficiency, homologous recombination repair, homologous recombination repair (HRR) genes, ovarian carcinoma, poly (ADP-ribose), poly (ADP-ribose) polymerase, poorly differentiated ovarian carcinoma, single nucleotide polymorphism (SNP) arrays, tumor, tumors
Author NameAffiliation
Volker EndrisInstitute of Pathology, Heidelberg University Hospital
Olaf NeumannInstitute of Pathology, Heidelberg University Hospital
Susanne BeckInstitute of Pathology, Heidelberg University Hospital, Germany Center for Personalized Medicine (ZPM) Heidelberg
Markus BallInstitute of Pathology, Heidelberg University Hospital
Stefan Fr??hlingCenter for Personalized Medicine (ZPM) Heidelberg
Peter Lichtner
Peter SchirmacherInstitute of Pathology, Heidelberg University Hospital, Germany Center for Personalized Medicine (ZPM) Heidelberg
Daniel KazdalInstitute of Pathology, Heidelberg University Hospital, Germany German Center for Lung Research (DZL)
Albrecht StenzingerInstitute of Pathology, Heidelberg University Hospital, Germany Center for Personalized Medicine (ZPM) Heidelberg, Germany German Center for Lung Research (DZL)
Jan BudcziesInstitute of Pathology, Heidelberg University Hospital, Germany Center for Personalized Medicine (ZPM) Heidelberg, Germany German Center for Lung Research (DZL)
  • 1 - 10

Datasets

Release 1.2